scispace - formally typeset
R

Ricardo Gargini

Researcher at Autonomous University of Madrid

Publications -  13
Citations -  5249

Ricardo Gargini is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 5 publications receiving 4805 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Daniel J. Klionsky, +2522 more
- 01 Jan 2016 - 
TL;DR: Author(s): Klionsky, DJ; Abdelmohsen, K; Abe, A; Abedin, MJ; Abeliovich, H; A Frozena, AA; Adachi, H, Adeli, K, Adhihetty, PJ; Adler, SG; Agam, G; Agarwal, R; Aghi, MK; Agnello, M; Agostinis, P; Aguilar, PV; Aguirre-Ghis
Journal ArticleDOI

IDP-410: a Novel Therapeutic Peptide that Alters N-MYC Stability and Reduces Angiogenesis and Tumor Progression in Glioblastomas

TL;DR: In this article , a stapled peptide designed to specifically target N-MYC protein monomer, IDP-410, is able to impair the formation of N-myC/MAX complex and reduce the stability of the N-MyC itself.
Journal ArticleDOI

Tauopathies: The Role of Tau in Cellular Crosstalk and Synaptic Dysfunctions

TL;DR: In this paper , a review shows how tau inclusions in glia influence the synaptic dysfunctions that result in the cognitive symptoms characteristic of tauopathies, including Alzheimer's disease.
Journal ArticleDOI

IDP-410: a Novel Therapeutic Peptide that Alters N-MYC Stability and Reduces Angiogenesis and Tumor Progression in Glioblastomas

TL;DR: In this article , a stapled peptide designed to specifically target N-MYC protein monomer, IDP-410, is able to impair the formation of N-myC/MAX complex and reduce the stability of the N-MyC itself.